Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group

Fløtten, Ø., Grønberg, B. H., Bremnes, R. M., Amundsen, T., Sundstrøm, S. H., Rolke, H., HORNSLIEN, K., Wentzel-Larsen, T., Aasebø, U., & von Plessen, C. (2012). Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group. British Journal of Cancer, 107(3), 442-447. doi:10.1038/bjc.2012.284